“I am very excited about this program that covers many aspects of Alzheimer’s Disease, bridging cutting-edge research to developments in the clinic,” said Bruce Morimoto, Vice President of Drug Development at Allon Therapeutics and Conference Co-Chairman. “This conference is the best in the industry because presentations will include the latest in our understanding of the mechanism of AD as well as a discussion of biomarkers and clinical endpoints.”

Added Conference Co-Chairman, Franz Hefti, Vice President of Neuroscience at Avid Radiopharmaceuticals, “I am proud to be a part of a conference that will cover the latest developments in Aâ-targeted therapies, new advances and accomplishments with imaging in AD and six case studies providing an in-depth look at current AD research.”

Join your colleagues on May 1-2, 2008 at the Hilton Back Bay in Boston, MA for this exciting two-day program. Come and be a part of the discussion about the tremendous progress made in understanding the nature and treatment of Alzheimer’s Disease.

For complete program agenda and information including registration and hotel booking, please visit www.almevents.com/alzheimers.

The Strategic Research Institute is part of ALM’s Conference and Trade Show Division, one of North America’s largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 200 conferences and two leading industry tradeshows annually, on a broad range of topics.

ALM is a leading integrated media company, focused on the legal, real estate and business communities. ALM currently publishes 33 national and regional magazines and newspapers. Other ALM businesses include online, book and newsletter publishing, market research and content distribution. More information on ALM is available at www.alm.com. ALM is an Incisive Media company.